AI has advanced molecule design, yet synthetic feasibility remains a bottleneck. Chemistry-first approaches offer a practical ...

A breakthrough study reveals a new antibody that could transform the fight against HIV, neutralising over 98 percent of ...

Despite decades of intensive research, truly effective therapies for neurodegenerative diseases remain elusive. Conditions such as Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), ...

A new study shows that approved drugs, pemafibrate and telmisartan, when combined, can reduce liver fat and may lower cardiovascular risk in metabolic dysfunction-associated steatotic liver disease.